Recent studies have suggested that kin17 is highly expressed in a variety of malignant tumors, such as breast cancer, lung cancer, liver cancer, and melanoma, and it is closely related to tumorigenesis and progression of these tumors [8–11]. This evidence concerns the gene KIN and breast carcinoma.